Regencell Bioscience Holdings Ltd
RGCNasdaqHealthcare · Medicinal Chemicals & Botanical Products · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Regencell (Bvi) LtdActivist (13D)Jul 11, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 797,139 | 7.2 | +3.2% |
| Apr 30, 2026 | 772,547 | 8.0 | -7.0% |
| Apr 15, 2026 | 830,632 | 3.4 | +18.6% |
| Mar 31, 2026 | 700,509 | 5.2 | +15.5% |
| Mar 13, 2026 | 606,522 | 5.5 | -4.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 4May 29, 2026
- 4May 29, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 22, 2026
- 424B5PROSPECTUS SUPPLEMENTMay 19, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 19, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 19, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 8, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 17, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 30, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 30, 2026
- 424B5PROSPECTUS SUPPLEMENTMar 30, 2026
- F-3ASRREGISTRATION STATEMENTMar 30, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
- 3Mar 18, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.